OHIP won't pay for dying mom's drugs

Kimm Fletcher, 41, holds a photo of her family at Queen's Park on Oct. 30, 2013. (Antonella...

Kimm Fletcher, 41, holds a photo of her family at Queen's Park on Oct. 30, 2013. (Antonella Artuso/QMI Agency)

Christina Blizzard, Queen's Park Senior Columnist

, Last Updated: 7:58 AM ET

TORONTO -- Tell me how you do it.

How do you tell two children ages seven and nine that their mom has only two months to live?

How do you tell those children there could be an empty seat at the table this Christmas?

Then how do you tell those children that there's a drug that could give their mom another 18 months of life -- but the government has turned her down for coverage for that drug?

Those are the heart-wrenching questions Kimm Fletcher, 41, brought to Queen's Park Wednesday. The Milton mom is living with a two-month death sentence.

Diagnosed with a brain tumour in 2010, Kimm got bad news recently that it has grown. Doctors told her the best chance to prolong her life is the drug Avastin. As if life hadn't already dealt her a bad enough hand, her government piled on.

Avastin isn't covered by OHIP -- and treatment costs $100,000 a year.

It could give her a chance for as much as 18 more months of life.

That's two precious Christmases to spend with her son, Keidon, 9, daughter Martie, 7, and her husband, Scott.

"It will allow me to be with my family and to give my kids some positive memories time with my family," courageous Kimm told reporters Wednesday.

Friends, family and her community did what good people always do when the chips are down. They rallied and fund-raised for her -- $48,000 so far.

She's only had one treatment, but overnight went from being bedridden to walking her daughter to school.

If she lived in Saskatchewan, Manitoba or B.C., the province's health insurance plan would cover the drug.


Videos

Photos